ConductScience.org, home

Paper7471604

Effect of dose on acetylator phenotype distribution of hydralazine.

Timbrell JA and 2 others. Clin Pharmacol Ther, 1981. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Effect of dose on acetylator phenotype distribution of hydralazine. Papers, record 7471604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7471604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of dose on acetylator phenotype distribution of hydralazine.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1981
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2019-05-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Timbrell JAJ A
2Harland SJS J
3Facchini VV

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HydralazineMajor topic
Acetylation
Dose-Response Relationship, Drug
Humans
Phenotype
Phthalazines
Triazoles

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
36068466Pharmacogenomics Informs Cardiovascular Pharmacotherapy.Methods Mol Biol2022https://conductscience.org/library/papers/36068466PubMed
33094670Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.Expert Opin Drug Metab Toxicol2021https://conductscience.org/library/papers/33094670PubMed
32927458Genotype-Guided Hydralazine Therapy.Am J Nephrol2020https://conductscience.org/library/papers/32927458PubMed
7047041Clinical pharmacokinetics of hydralazine.Clin Pharmacokinet1982https://conductscience.org/library/papers/7047041PubMed
6861845Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6861845PubMed
3758143Evaluation of once daily endralazine in hypertension.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3758143PubMed
3530584Clinical pharmacokinetics of dapsone.Clin Pharmacokinet1986https://conductscience.org/library/papers/3530584PubMed
2656046Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.Clin Pharmacokinet1989https://conductscience.org/library/papers/2656046PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7471604

GET https://conductscience.org/api/papers/v1/7471604/authors